Published in Cancer Biol Ther on February 23, 2007
Effect of high amylose maize starches on colonic fermentation and apoptotic response to DNA-damage in the colon of rats. Nutr Metab (Lond) (2009) 1.13
Dietary red meat aggravates dextran sulfate sodium-induced colitis in mice whereas resistant starch attenuates inflammation. Dig Dis Sci (2013) 0.83
Polymorphisms in NFKB1 and TLR4 and interaction with dietary and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study. PLoS One (2015) 0.81
Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res (2003) 17.13
Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer (2006) 2.47
Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst (2012) 2.44
Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut (2010) 2.30
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol (2012) 2.22
A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. J Natl Cancer Inst (2012) 1.83
Interval fecal immunochemical testing in a colonoscopic surveillance program speeds detection of colorectal neoplasia. Gastroenterology (2010) 1.74
Shift to earlier stage at diagnosis as a consequence of the National Bowel Cancer Screening Program. Med J Aust (2013) 1.73
Applying evidence-based guidelines improves use of colonoscopy resources in patients with a moderate risk of colorectal neoplasia. Med J Aust (2002) 1.73
Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat (2013) 1.55
Evaluation of oral rehydration solution by whole-gut perfusion in rats: effect of osmolarity, sodium concentration and resistant starch. J Pediatr Gastroenterol Nutr (2006) 1.41
Mannose-binding lectin deficiency does not increase the prevalence of Helicobacter pylori seropositivity. Eur J Gastroenterol Hepatol (2007) 1.38
Colorectal Neoplasia Differentially Expressed (CRNDE), a Novel Gene with Elevated Expression in Colorectal Adenomas and Adenocarcinomas. Genes Cancer (2011) 1.28
Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. Int J Colorectal Dis (2010) 1.27
A panel of genes methylated with high frequency in colorectal cancer. BMC Cancer (2014) 1.26
Protocol for population testing of an Internet-based Personalised Decision Support system for colorectal cancer screening. BMC Med Inform Decis Mak (2010) 1.24
Psychosocial variables associated with colorectal cancer screening in South Australia. Int J Behav Med (2011) 1.17
Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantation. Stem Cells (2009) 1.14
Effect of high amylose maize starches on colonic fermentation and apoptotic response to DNA-damage in the colon of rats. Nutr Metab (Lond) (2009) 1.13
Map of differential transcript expression in the normal human large intestine. Physiol Genomics (2007) 1.11
A synbiotic combination of resistant starch and Bifidobacterium lactis facilitates apoptotic deletion of carcinogen-damaged cells in rat colon. J Nutr (2005) 1.05
Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers. Ann Surg Oncol (2013) 1.03
Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: a population study. BMC Public Health (2014) 1.01
Effect of dietary resistant starch and protein on colonic fermentation and intestinal tumourigenesis in rats. Carcinogenesis (2006) 1.00
Predictors of re-participation in faecal occult blood test- based screening for colorectal cancer. Asian Pac J Cancer Prev (2012) 0.97
Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia detection in a Chinese population. Cancer (2003) 0.97
Amylase-resistant starch as adjunct to oral rehydration therapy in children with diarrhea. J Pediatr Gastroenterol Nutr (2006) 0.96
Comparing fecal immunochemical tests: improved standardization is needed. Gastroenterology (2012) 0.95
Effect of resistant starch on genotoxin-induced apoptosis, colonic epithelium, and lumenal contents in rats. Carcinogenesis (2003) 0.94
Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis (2009) 0.93
Colorectal cancer linkage on chromosomes 4q21, 8q13, 12q24, and 15q22. PLoS One (2012) 0.93
Absence of acute apoptotic response to genotoxic carcinogens in p53-deficient mice is associated with increased susceptibility to azoxymethane-induced colon tumours. Int J Cancer (2005) 0.93
Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers? Eur J Cancer (2013) 0.92
Suppression of azoxymethane-induced colon cancer development in rats by dietary resistant starch. Cancer Biol Ther (2007) 0.89
Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing. PLoS One (2012) 0.89
Effects of high-amylose maize starch and butyrylated high-amylose maize starch on azoxymethane-induced intestinal cancer in rats. Carcinogenesis (2008) 0.88
Suppression of colorectal oncogenesis by selenium-enriched milk proteins: apoptosis and K-ras mutations. Cancer Res (2008) 0.88
Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis. Fam Cancer (2009) 0.87
Inhibition by resistant starch of red meat-induced promutagenic adducts in mouse colon. Cancer Prev Res (Phila) (2011) 0.86
Demographic associations with stage of readiness to screen for colorectal cancer. Health Promot J Austr (2009) 0.84
Sulindac corrects defective apoptosis and suppresses azoxymethane-induced colonic oncogenesis in p53 knockout mice. Int J Cancer (2005) 0.84
A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr (2009) 0.84
Improving the reporting of evaluations of faecal immunochemical tests for haemoglobin: the FITTER standard and checklist. Eur J Cancer Prev (2015) 0.84
Using the Transtheoretical Model of Behaviour Change to describe readiness to rescreen for colorectal cancer with faecal occult blood testing. Health Promot J Austr (2012) 0.83
Butyrate delivered by butyrylated starch increases distal colonic epithelial apoptosis in carcinogen-treated rats. Carcinogenesis (2011) 0.83
Dietary red meat aggravates dextran sulfate sodium-induced colitis in mice whereas resistant starch attenuates inflammation. Dig Dis Sci (2013) 0.83
Making colorectal cancer screening FITTER for purpose with quantitative faecal immunochemical tests for haemoglobin (FIT). Clin Chem Lab Med (2013) 0.83
The urgency of saving lives through bowel cancer screening. Med J Aust (2012) 0.83
Repair and removal of azoxymethane-induced O6-methylguanine in rat colon by O6-methylguanine DNA methyltransferase and apoptosis. Mutat Res (2013) 0.83
Selenium-rich foods: a promising approach to colorectal cancer prevention. Curr Pharm Biotechnol (2012) 0.82
Evidence of linkage to chromosomes 10p15.3-p15.1, 14q24.3-q31.1 and 9q33.3-q34.3 in non-syndromic colorectal cancer families. Eur J Hum Genet (2011) 0.82
Quantitation of hemoglobin improves fecal immunochemical tests for noninvasive screening. Clin Gastroenterol Hepatol (2013) 0.82
Detection of K-ras mutations in azoxymethane-induced aberrant crypt foci in mice using LNA-mediated real-time PCR clamping and mutant-specific probes. Mutat Res (2009) 0.82
Ambivalence and its influence on participation in screening for colorectal cancer. Qual Health Res (2013) 0.82
A randomized controlled trial of glucose versus amylase resistant starch hypo-osmolar oral rehydration solution for adult acute dehydrating diarrhea. PLoS One (2008) 0.81
Accumulation of promutagenic DNA adducts in the mouse distal colon after consumption of heme does not induce colonic neoplasms in the western diet model of spontaneous colorectal cancer. Mol Nutr Food Res (2013) 0.81
Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer. Eur J Gastroenterol Hepatol (2006) 0.81
Combination of selenium and green tea improves the efficacy of chemoprevention in a rat colorectal cancer model by modulating genetic and epigenetic biomarkers. PLoS One (2013) 0.81
DNA methylation in the rectal mucosa is associated with crypt proliferation and fecal short-chain fatty acids. Dig Dis Sci (2010) 0.81
Colorectal cancer screening in rural and remote areas: analysis of the National Bowel Cancer Screening Program data for South Australia. Rural Remote Health (2011) 0.81
Rising incidence of early-onset colorectal cancer in Australia over two decades: report and review. J Gastroenterol Hepatol (2015) 0.81
Improving Participation in Colorectal Cancer Screening: a Randomised Controlled Trial of Sequential Offers of Faecal then Blood Based Non-Invasive Tests. Asian Pac J Cancer Prev (2015) 0.80
Selenium-enriched milk proteins and selenium yeast affect selenoprotein activity and expression differently in mouse colon. Br J Nutr (2010) 0.80
Sensitive and selective amplification of methylated DNA sequences using helper-dependent chain reaction in combination with a methylation-dependent restriction enzymes. Nucleic Acids Res (2012) 0.79
The influence of selenium-enriched milk proteins and selenium yeast on plasma selenium levels and rectal selenoprotein gene expression in human subjects. Br J Nutr (2011) 0.79
Fecal Tests: From Blood to Molecular Markers. Curr Colorectal Cancer Rep (2011) 0.79
Anti-mutagenic lichen extract has double-edged effect on azoxymethane-induced colorectal oncogenesis in C57BL/6J mice. Toxicol Mech Methods (2010) 0.78
The potential of sphingomyelin as a chemopreventive agent in AOM-induced colon cancer model: wild-type and p53+/- mice. Mol Nutr Food Res (2008) 0.78
R-flurbiprofen suppresses distal nonmucin-producing colorectal tumors in azoxymethane-treated rats, without suppressing eicosanoid production. Am J Physiol Gastrointest Liver Physiol (2010) 0.78
Oral rehydration therapy in the second decade of the twenty-first century. Curr Gastroenterol Rep (2014) 0.78
Treatment patterns among colorectal cancer patients in South Australia: a demonstration of the utility of population-based data linkage. J Eval Clin Pract (2014) 0.77
A standard for Faecal Immunochemical TesTs for haemoglobin evaluation reporting (FITTER). Ann Clin Biochem (2013) 0.77
Defective acute apoptotic response to genotoxic carcinogen in small intestine of APC(Min/+) mice is restored by sulindac. Cancer Lett (2006) 0.77
Comparing the effects of COX and non-COX-inhibiting NSAIDs on enhancement of apoptosis and inhibition of aberrant crypt foci formation in a rat colorectal cancer model. Anticancer Res (2013) 0.77
Newer fecal tests: opportunities for professionals in laboratory medicine. Clin Chem (2012) 0.77
Participant satisfaction with fecal occult blood test screening for colorectal cancer. J Gastroenterol Hepatol (2007) 0.77
Exploring the validity of the continuum of resistance model for discriminating early from late and non-uptake of colorectal cancer screening: implications for the design of invitation and reminder letters. Int J Behav Med (2013) 0.76
Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med (2009) 0.76
Role of Red Meat and Resistant Starch in Promutagenic Adduct Formation, MGMT Repair, Thymic Lymphoma and Intestinal Tumourigenesis in Msh2 -Deficient Mice. J Nutrigenet Nutrigenomics (2015) 0.76
Little evidence for association between the TGFBR1*6A variant and colorectal cancer: a family-based association study on non-syndromic family members from Australia and Spain. BMC Cancer (2014) 0.75
Fecal DNA for colorectal-cancer screening. N Engl J Med (2005) 0.75
Patient and carer perceptions of cancer care in South Australia. Aust Health Rev (2009) 0.75
Inhibition of oxidative stress and apoptosis enables extended maintenance of integrity and function of isolated hepatocytes in suspension. J Gastroenterol Hepatol (2009) 0.75
Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test. Eur J Cancer Prev (2017) 0.75
Screening with a fecal multitarget DNA test. Gastroenterology (2005) 0.75